Crossmark

Switching to ranibizumab in diabetic macular oedema refractory to bevacizumab treatment

Crossref DOI link: https://doi.org/10.1016/j.oftale.2018.04.003

Published Print: 2018-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ashraf, M.

Souka, A.A.

Daich Varela, M.

el Kayal, H.

Schlottmann, P.G.
License Information

Text and Data Mining valid from 2018-11-01
More Information

This article is maintained by: Elsevier

Article Title: Switching to ranibizumab in diabetic macular oedema refractory to bevacizumab treatment

Journal Title: Archivos de la Sociedad Española de Oftalmología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.oftale.2018.04.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.oftal.2018.04.001

Content Type: article

Copyright: © 2018 Sociedad Española de Oftalmología. Published by Elsevier España, S.L.U. All rights reserved.